PCSK9 Inhibitor [EPC]

PCSK9 Inhibitor [EPC] was reported 25752 times

These side effects are most commonly reported by patients taking drugs of the PCSK9 Inhibitor [EPC] class:

# Drug class Count
0 DEVICE DIFFICULT TO USE 33307
1 DRUG DOSE OMISSION BY DEVICE 25089
2 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22769
3 ACCIDENTAL EXPOSURE TO PRODUCT 17230
4 INJECTION SITE PAIN 12599
5 MYALGIA 7078
6 PRODUCT STORAGE ERROR 7071
7 BACK PAIN 6128
8 INJECTION SITE BRUISING 5820
9 DRUG DOSE OMISSION 5254
10 FATIGUE 5164
11 ARTHRALGIA 5162
12 INJECTION SITE HAEMORRHAGE 4864
13 PAIN IN EXTREMITY 4478
14 DEVICE USE ERROR 4435
15 MUSCLE SPASMS 4374
16 OFF LABEL USE 4303
17 RHINORRHOEA 4187
18 PAIN 4124
19 INFLUENZA LIKE ILLNESS 3989
20 HEADACHE 3915
21 DIARRHOEA 3413
22 PRODUCT PREPARATION ERROR 3226
23 NAUSEA 3222
24 INCORRECT DOSE ADMINISTERED BY DEVICE 3204
25 DIZZINESS 3188
26 NASOPHARYNGITIS 3109
27 DYSPNOEA 2959
28 PRODUCT COMMUNICATION ISSUE 2939
29 COUGH 2930
30 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2882
31 INJECTION SITE ERYTHEMA 2686
32 RASH 2629
33 MALAISE 2588
34 INJECTION SITE SWELLING 2582
35 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2523
36 DEVICE ISSUE 2472
37 PRURITUS 2397
38 PRODUCT DOSE OMISSION ISSUE 2379
39 ASTHENIA 2282
40 FEELING ABNORMAL 2142
41 BLOOD GLUCOSE INCREASED 2014
42 PRODUCT DOSE OMISSION 2009
43 DRUG INEFFECTIVE 1920
44 INJURY ASSOCIATED WITH DEVICE 1874
45 DEATH 1843
46 OROPHARYNGEAL PAIN 1806
47 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1747
48 INCORRECT DISPOSAL OF PRODUCT 1746
49 INJECTION SITE MASS 1669
50 MYOCARDIAL INFARCTION 1653
51 BLOOD CHOLESTEROL INCREASED 1648
52 UNDERDOSE 1631
53 LOW DENSITY LIPOPROTEIN INCREASED 1540
54 GAIT DISTURBANCE 1515
55 MEMORY IMPAIRMENT 1506
56 INFLUENZA 1491
57 MUSCULAR WEAKNESS 1484
58 INJECTION SITE PRURITUS 1442
59 CHEST PAIN 1369
60 FALL 1353
61 HYPERSENSITIVITY 1347
62 UNEVALUABLE EVENT 1298
63 WEIGHT INCREASED 1271
64 CEREBROVASCULAR ACCIDENT 1266
65 WEIGHT DECREASED 1243
66 URTICARIA 1213
67 ABDOMINAL PAIN UPPER 1182
68 PERIPHERAL SWELLING 1178
69 INCORRECT DOSE ADMINISTERED 1134
70 BLOOD PRESSURE INCREASED 1096
71 HYPERTENSION 1073
72 VOMITING 1057
73 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1057
74 THERAPY INTERRUPTED 1056
75 INSOMNIA 1015
76 INTENTIONAL PRODUCT MISUSE 988
77 ABDOMINAL DISCOMFORT 986
78 PNEUMONIA 974
79 CONTUSION 965
80 HOSPITALISATION 965
81 OCCUPATIONAL EXPOSURE TO PRODUCT 960
82 ADVERSE EVENT 947
83 MUSCULOSKELETAL PAIN 946
84 URINARY TRACT INFECTION 926
85 PYREXIA 917
86 HYPOACUSIS 903
87 INJECTION SITE REACTION 897
88 NASAL CONGESTION 896
89 MOBILITY DECREASED 881
90 SINUSITIS 878
91 CHEST DISCOMFORT 860
92 ALOPECIA 854
93 LOW DENSITY LIPOPROTEIN DECREASED 851
94 VISUAL IMPAIRMENT 846
95 HYPOAESTHESIA 839
96 CARDIAC DISORDER 836
97 ANXIETY 830
98 EXPOSURE VIA SKIN CONTACT 820
99 PARAESTHESIA 820
100 ERYTHEMA 815
101 ARTHRITIS 811
102 INJECTION SITE RASH 797
103 COVID-19 795
104 DIABETES MELLITUS 774
105 DYSPHONIA 771
106 BLOOD TRIGLYCERIDES INCREASED 753
107 CONDITION AGGRAVATED 746
108 MUSCULOSKELETAL STIFFNESS 721
109 ABDOMINAL PAIN 720
110 PRODUCT ADMINISTRATION ERROR 713
111 RASH PRURITIC 698
112 CONSTIPATION 695
113 NECK PAIN 693
114 INJECTION SITE DISCOLOURATION 674
115 DECREASED APPETITE 670
116 DRUG HYPERSENSITIVITY 670
117 ILLNESS 666
118 ADVERSE DRUG REACTION 665
119 DEVICE MALFUNCTION 661
120 FEAR OF INJECTION 658
121 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 658
122 INJECTION SITE URTICARIA 647
123 CHILLS 645
124 THERAPY NON-RESPONDER 643
125 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 619
126 PRODUCT DELIVERY MECHANISM ISSUE 612
127 HYPERHIDROSIS 608
128 DEPRESSION 603
129 BRONCHITIS 596
130 ILL-DEFINED DISORDER 594
131 INJECTION SITE DISCOMFORT 585
132 ATRIAL FIBRILLATION 584
133 BONE PAIN 582
134 CONFUSIONAL STATE 579
135 PALPITATIONS 578
136 TREMOR 577
137 PRODUCT USE ISSUE 575
138 VISION BLURRED 564
139 JOINT SWELLING 559
140 BLOOD CHOLESTEROL DECREASED 546
141 THERAPEUTIC RESPONSE UNEXPECTED 546
142 DEVICE USE ISSUE 545
143 SURGERY 543
144 ABDOMINAL DISTENSION 542
145 NEUROPATHY PERIPHERAL 523
146 AMNESIA 518
147 GLYCOSYLATED HAEMOGLOBIN INCREASED 516
148 BURNING SENSATION 514
149 SWELLING 508
150 SINUS DISORDER 489
151 SWELLING FACE 488
152 STENT PLACEMENT 464
153 INJECTION SITE INDENTATION 463
154 BLOOD CREATINE PHOSPHOKINASE INCREASED 456
155 DRY MOUTH 450
156 UPPER RESPIRATORY TRACT INFECTION 448
157 DRUG INTOLERANCE 440
158 GASTROINTESTINAL DISORDER 436
159 DEVICE DEFECTIVE 425
160 SOMNOLENCE 425
161 THERAPY CESSATION 420
162 HEPATIC ENZYME INCREASED 414
163 SNEEZING 412
164 MIGRAINE 409
165 BALANCE DISORDER 404
166 THROAT IRRITATION 402
167 HYPOTENSION 401
168 DYSPEPSIA 399
169 ARTHROPATHY 398
170 ADVERSE REACTION 397
171 LIMB DISCOMFORT 397
172 HEART RATE INCREASED 393
173 DRUG EFFECT INCOMPLETE 388
174 ASTHMA 386
175 CARDIAC OPERATION 386
176 CATARACT 385
177 ANGINA PECTORIS 384
178 LETHARGY 382
179 VERTIGO 380
180 SLEEP DISORDER 378
181 NERVOUSNESS 375
182 DYSPHAGIA 370
183 PRODUCTIVE COUGH 355
184 FEELING HOT 352
185 LABORATORY TEST ABNORMAL 349
186 CORONARY ARTERY DISEASE 344
187 FLATULENCE 341
188 NEOPLASM MALIGNANT 338
189 WHEEZING 338
190 HOT FLUSH 337
191 DISCOMFORT 330
192 GASTROOESOPHAGEAL REFLUX DISEASE 330
193 DEHYDRATION 329
194 LOSS OF CONSCIOUSNESS 328
195 INJECTION SITE WARMTH 325
196 EPISTAXIS 324
197 INJECTION SITE INDURATION 323
198 MUSCULOSKELETAL DISORDER 322
199 STRESS 320
200 FLUSHING 314
201 PRURITUS GENERALISED 313
202 SYNCOPE 308
203 DYSPNOEA EXERTIONAL 307
204 RASH ERYTHEMATOUS 307
205 DRY SKIN 304
206 INJECTION SITE EXTRAVASATION 300
207 DYSGEUSIA 297
208 HERPES ZOSTER 294
209 TINNITUS 291
210 PRODUCT PREPARATION ISSUE 290
211 CORONARY ARTERY OCCLUSION 281
212 DEMENTIA 281
213 MUSCLE DISORDER 278
214 GAIT INABILITY 277
215 MUSCULOSKELETAL DISCOMFORT 273
216 RESPIRATORY TRACT CONGESTION 270
217 POLLAKIURIA 269
218 SECRETION DISCHARGE 268
219 THERAPEUTIC RESPONSE DECREASED 268
220 PANCREATITIS 264
221 COGNITIVE DISORDER 263
222 TRANSIENT ISCHAEMIC ATTACK 262
223 CARDIAC FAILURE 259
224 LIP SWELLING 259
225 PRODUCT DISPENSING ERROR 258
226 RENAL DISORDER 257
227 INFECTION 254
228 INJECTION SITE VESICLES 250
229 INTENTIONAL DOSE OMISSION 250
230 BLOOD CHOLESTEROL ABNORMAL 247
231 SKIN DISCOLOURATION 246
232 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 245
233 EYE DISORDER 244
234 JOINT STIFFNESS 242
235 SWOLLEN TONGUE 242
236 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 242
237 BACK DISORDER 241
238 SKIN EXFOLIATION 240
239 THROMBOSIS 240
240 MUSCLE TIGHTNESS 239
241 LACRIMATION INCREASED 235
242 LOW DENSITY LIPOPROTEIN ABNORMAL 235
243 UPPER-AIRWAY COUGH SYNDROME 234
244 RASH GENERALISED 233
245 OEDEMA PERIPHERAL 230
246 BLOOD PRESSURE DECREASED 229
247 EYE PAIN 229
248 THERAPEUTIC PRODUCT EFFECT DECREASED 228
249 PRODUCT USE IN UNAPPROVED INDICATION 225
250 BLOOD GLUCOSE DECREASED 224
251 CORONARY ARTERY BYPASS 223
252 DRY EYE 222
253 KNEE ARTHROPLASTY 221
254 RENAL IMPAIRMENT 221
255 RHEUMATOID ARTHRITIS 220
256 RASH MACULAR 219
257 BLISTER 218
258 DYSSTASIA 216
259 NEEDLE ISSUE 216
260 CARDIAC FAILURE CONGESTIVE 215
261 DISABILITY 213
262 ANAEMIA 212
263 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 210
264 RENAL FAILURE 210
265 NEPHROLITHIASIS 208
266 ALANINE AMINOTRANSFERASE INCREASED 207
267 SINUS CONGESTION 207
268 HEAD DISCOMFORT 206
269 LACK OF INJECTION SITE ROTATION 205
270 PRODUCT KNOWLEDGE DEFICIT 205
271 DISTURBANCE IN ATTENTION 203
272 SPINAL OPERATION 203
273 THROAT TIGHTNESS 202
274 DIVERTICULITIS 201
275 BRAIN FOG 197
276 FIBROMYALGIA 196
277 HAEMORRHAGE 195
278 INJECTION SITE IRRITATION 194
279 EYE SWELLING 193
280 RESPIRATORY DISORDER 193
281 ARRHYTHMIA 192
282 BLOOD PRESSURE ABNORMAL 191
283 DEVICE FAILURE 190
284 FLUID RETENTION 190
285 SEPSIS 189
286 PAIN IN JAW 186
287 LIMB INJURY 182
288 EAR PAIN 181
289 INFLAMMATION 181
290 ACUTE MYOCARDIAL INFARCTION 180
291 CORONARY ARTERIAL STENT INSERTION 180
292 EYE IRRITATION 179
293 FEELING COLD 179
294 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178
295 DRUG EFFECT LESS THAN EXPECTED 178
296 BLOOD GLUCOSE ABNORMAL 176
297 GASTRIC DISORDER 176
298 HIGH DENSITY LIPOPROTEIN DECREASED 175
299 LIVER FUNCTION TEST INCREASED 175
300 INCORRECT DOSE ADMINISTERED BY PRODUCT 173
301 NEURALGIA 173
302 SPEECH DISORDER 173
303 DEPRESSED MOOD 172
304 INJECTION SITE INJURY 172
305 PSORIASIS 172
306 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 171
307 ROAD TRAFFIC ACCIDENT 171
308 GOUT 170
309 ECZEMA 166
310 PLANTAR FASCIITIS 166
311 SEIZURE 165
312 SCIATICA 164
313 EXTRA DOSE ADMINISTERED 163
314 SENSATION OF FOREIGN BODY 163
315 LYMPHADENOPATHY 161
316 DYSURIA 160
317 HIP ARTHROPLASTY 160
318 NIGHT SWEATS 160
319 CYSTITIS 158
320 RUBBER SENSITIVITY 158
321 BLOOD CREATININE INCREASED 156
322 RASH PAPULAR 156
323 ASPARTATE AMINOTRANSFERASE INCREASED 155
324 ARTERIOSCLEROSIS 154
325 ARTERIAL OCCLUSIVE DISEASE 153
326 CATHETERISATION CARDIAC 153
327 DEAFNESS 152
328 APHONIA 151
329 BLINDNESS 151
330 INJECTION SITE HAEMATOMA 148
331 IRRITABILITY 148
332 VIRAL INFECTION 148
333 PRESYNCOPE 147
334 TACHYCARDIA 147
335 CHRONIC KIDNEY DISEASE 146
336 LIVER DISORDER 146
337 OBSTRUCTIVE SLEEP APNOEA SYNDROME 146
338 HIP FRACTURE 145
339 ACUTE KIDNEY INJURY 144
340 BREAST CANCER 144
341 SEASONAL ALLERGY 144
342 ANGIOEDEMA 143
343 DEVICE OPERATIONAL ISSUE 143
344 EYE PRURITUS 143
345 INCREASED TENDENCY TO BRUISE 143
346 CELLULITIS 142
347 LOWER RESPIRATORY TRACT INFECTION 142
348 LARYNGITIS 141
349 OBSTRUCTIVE AIRWAYS DISORDER 141
350 PARANASAL SINUS HYPERSECRETION 141
351 EXOSTOSIS 140
352 MUSCULOSKELETAL CHEST PAIN 139
353 CHROMATURIA 138
354 BRAIN NATRIURETIC PEPTIDE INCREASED 137
355 INTERCEPTED PRODUCT STORAGE ERROR 137
356 EOSINOPHILIA 136
357 MYOGLOBIN BLOOD INCREASED 134
358 DRUG INTERACTION 133
359 OSTEOARTHRITIS 133
360 RESPIRATORY TRACT INFECTION 133
361 CARDIAC ARREST 132
362 CARDIOVASCULAR DISORDER 132
363 RHABDOMYOLYSIS 132
364 OCULAR HYPERAEMIA 131
365 DRY THROAT 130
366 HYPERSOMNIA 130
367 ANAPHYLACTIC REACTION 129
368 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 128
369 HEAD INJURY 128
370 VASCULAR GRAFT 127
371 CHOLELITHIASIS 126
372 EAR INFECTION 125
373 PARAESTHESIA ORAL 125
374 PNEUMOTHORAX 124
375 GENERAL PHYSICAL HEALTH DETERIORATION 123
376 PRODUCT PRESCRIBING ERROR 122
377 SKIN DISORDER 122
378 ANGINA UNSTABLE 121
379 INCORRECT ROUTE OF DRUG ADMINISTRATION 121
380 LUNG DISORDER 121
381 MUSCLE ATROPHY 121
382 TYPE 2 DIABETES MELLITUS 121
383 INTERVERTEBRAL DISC PROTRUSION 120
384 PHARYNGEAL SWELLING 119
385 KNEE OPERATION 118
386 TOOTHACHE 118
387 DEVICE DISPENSING ERROR 117
388 MACULAR DEGENERATION 116
389 SKIN BURNING SENSATION 116
390 IRRITABLE BOWEL SYNDROME 114
391 JOINT INJURY 114
392 PROSTATE CANCER 114
393 GROIN PAIN 113
394 SKIN HAEMORRHAGE 112
395 GASTRITIS 111
396 OROPHARYNGEAL DISCOMFORT 111
397 PULMONARY EMBOLISM 111
398 SLUGGISHNESS 111
399 ACNE 109
400 ERECTILE DYSFUNCTION 109
401 HAEMOGLOBIN DECREASED 109
402 HEART RATE IRREGULAR 109
403 HEPATIC STEATOSIS 109
404 STOMATITIS 109
405 DISORIENTATION 108
406 HEART RATE DECREASED 108
407 RHINITIS 108
408 TENDONITIS 108
409 FREQUENT BOWEL MOVEMENTS 107
410 FUNGAL INFECTION 107
411 OEDEMA 107
412 PRODUCT SUPPLY ISSUE 107
413 MENTAL IMPAIRMENT 106
414 DRUG EFFECT DECREASED 105
415 PHARYNGEAL OEDEMA 104
416 NIGHTMARE 103
417 BLOOD PRESSURE FLUCTUATION 102
418 BLOOD URINE PRESENT 102
419 MUSCLE TWITCHING 102
420 OSTEOPOROSIS 102
421 KIDNEY INFECTION 101
422 MUSCLE FATIGUE 101
423 EXPIRED PRODUCT ADMINISTERED 100
424 ERUCTATION 99
425 EAR DISCOMFORT 98
426 LUNG NEOPLASM MALIGNANT 98
427 COLD SWEAT 96
428 PRODUCT QUALITY ISSUE 95
429 APHASIA 94
430 GASTROINTESTINAL PAIN 94
431 PULMONARY CONGESTION 94
432 BLOOD TEST ABNORMAL 93
433 CARDIAC PACEMAKER INSERTION 93
434 DEVICE LEAKAGE 93
435 HALLUCINATION 93
436 AGITATION 92
437 HAEMATOCHEZIA 92
438 HAEMATOMA 92
439 HYPOAESTHESIA ORAL 92
440 UPPER LIMB FRACTURE 92
441 GLUCOSE TOLERANCE IMPAIRED 91
442 INTENTIONAL PRODUCT USE ISSUE 91
443 RESTLESS LEGS SYNDROME 91
444 DISEASE PROGRESSION 90
445 GASTROENTERITIS VIRAL 90
446 INJECTION SITE INFLAMMATION 90
447 MASS 89
448 THINKING ABNORMAL 89
449 ABNORMAL DREAMS 88
450 AUTOIMMUNE DISORDER 88
451 FAECES DISCOLOURED 88
452 HIGH DENSITY LIPOPROTEIN INCREASED 88
453 INCREASED UPPER AIRWAY SECRETION 88
454 INJECTION SITE HYPERSENSITIVITY 88
455 INJECTION SITE HYPOAESTHESIA 88
456 POST PROCEDURAL COMPLICATION 88
457 HYPERGLYCAEMIA 87
458 LOCALISED INFECTION 87
459 MENTAL DISORDER 87
460 MUSCLE STRAIN 87
461 IMPAIRED WORK ABILITY 86
462 INCREASED APPETITE 86
463 SKIN PRESSURE MARK 86
464 SKIN ULCER 86
465 SLEEP APNOEA SYNDROME 86
466 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86
467 APPLICATION SITE PAIN 85
468 GLAUCOMA 85
469 HYPOGLYCAEMIA 85
470 LIPOPROTEIN (A) INCREASED 85
471 NERVOUS SYSTEM DISORDER 85
472 POOR QUALITY SLEEP 85
473 URINARY INCONTINENCE 85
474 CEREBRAL INFARCTION 84
475 DEMENTIA ALZHEIMER^S TYPE 84
476 EYE OPERATION 84
477 GASTROINTESTINAL HAEMORRHAGE 84
478 LOWER LIMB FRACTURE 84
479 PLEURAL EFFUSION 84
480 PRODUCT ADMINISTRATION INTERRUPTED 84
481 THYROID DISORDER 84
482 PLATELET COUNT DECREASED 83
483 SUICIDAL IDEATION 83
484 TASTE DISORDER 83
485 THIRST 83
486 TREATMENT NONCOMPLIANCE 83
487 DIALYSIS 82
488 HYPOTHYROIDISM 82
489 PROCEDURAL PAIN 82
490 SPINAL FRACTURE 82
491 WOUND 82
492 ARTERIOSCLEROSIS CORONARY ARTERY 81
493 DIPLOPIA 81
494 GALLBLADDER DISORDER 81
495 HERNIA 81
496 MYOPATHY 81
497 RENAL PAIN 81
498 BLOOD POTASSIUM DECREASED 80
499 FEELING JITTERY 80
500 LIPIDS INCREASED 80
501 OXYGEN SATURATION DECREASED 80
502 BLOOD PRESSURE SYSTOLIC INCREASED 78
503 CHOKING 78
504 PRODUCT DOSE OMISSION IN ERROR 78
505 ROTATOR CUFF SYNDROME 78
506 BLOOD POTASSIUM INCREASED 77
507 IMMUNE SYSTEM DISORDER 77
508 PRODUCT TEMPERATURE EXCURSION ISSUE 77
509 TOOTH DISORDER 77
510 TYPE IIA HYPERLIPIDAEMIA 77
511 ABDOMINAL PAIN LOWER 76
512 GASTROENTERITIS 76
513 ORAL PAIN 76
514 PAPULE 76
515 PARKINSON^S DISEASE 76
516 PERIPHERAL COLDNESS 76
517 CAROTID ARTERY OCCLUSION 75
518 PULMONARY OEDEMA 75
519 DYSARTHRIA 74
520 INJECTION SITE NODULE 74
521 NERVE COMPRESSION 74
522 TENDON RUPTURE 74
523 WHITE BLOOD CELL COUNT DECREASED 74
524 COLITIS 73
525 HYPERCHOLESTEROLAEMIA 73
526 INJURY 73
527 ORAL HERPES 73
528 PHARYNGITIS 73
529 CORONARY ARTERY STENOSIS 72
530 VASCULAR OCCLUSION 72
531 ARTHROPOD BITE 71
532 BONE DISORDER 71
533 IMPAIRED HEALING 71
534 MOVEMENT DISORDER 71
535 RESTLESSNESS 71
536 TENDERNESS 71
537 THROMBOCYTOPENIA 71
538 AGEUSIA 70
539 CHOLECYSTECTOMY 70
540 DEEP VEIN THROMBOSIS 70
541 MIDDLE INSOMNIA 70
542 MYOSITIS 70
543 PANIC ATTACK 70
544 SINUS HEADACHE 70
545 VIRAL UPPER RESPIRATORY TRACT INFECTION 70
546 HYPOKINESIA 69
547 PSORIATIC ARTHROPATHY 69
548 SKIN LACERATION 69
549 BLOOD GLUCOSE FLUCTUATION 68
550 BURSITIS 68
551 STAPHYLOCOCCAL INFECTION 68
552 TENDON PAIN 68
553 INSURANCE ISSUE 67
554 SCRATCH 67
555 SYSTEMIC LUPUS ERYTHEMATOSUS 67
556 WRIST FRACTURE 67
557 CARDIAC FLUTTER 66
558 DEVICE DELIVERY SYSTEM ISSUE 66
559 INJECTION SITE PARAESTHESIA 66
560 RECTAL HAEMORRHAGE 66
561 SKIN LESION 66
562 SKIN REACTION 66
563 SPINAL PAIN 66
564 BEDRIDDEN 65
565 CARPAL TUNNEL SYNDROME 65
566 FEEDING DISORDER 65
567 INTESTINAL OBSTRUCTION 65
568 OCULAR DISCOMFORT 65
569 ABNORMAL FAECES 64
570 ACCIDENT 64
571 BOWEL MOVEMENT IRREGULARITY 64
572 BRONCHOSPASM 64
573 CEREBRAL HAEMORRHAGE 64
574 HEPATIC FUNCTION ABNORMAL 64
575 HUNGER 64
576 ABASIA 63
577 HAEMATURIA 63
578 LIMB OPERATION 63
579 RETCHING 63
580 ANKLE FRACTURE 62
581 DIZZINESS POSTURAL 62
582 NO ADVERSE EVENT 62
583 URINARY RETENTION 61
584 URINE ODOUR ABNORMAL 61
585 DERMATITIS CONTACT 60
586 FACIAL PAIN 60
587 INJECTION SITE DISCHARGE 60
588 WHITE BLOOD CELL COUNT INCREASED 60
589 DERMATITIS 59
590 FOOT FRACTURE 59
591 MULTIPLE USE OF SINGLE-USE PRODUCT 59
592 SKIN IRRITATION 59
593 SPINAL STENOSIS 59
594 ANGIOPATHY 58
595 BRADYCARDIA 58
596 CEREBRAL DISORDER 58
597 DRUG DELIVERY SYSTEM MALFUNCTION 58
598 DRUG DISPENSING ERROR 58
599 FLANK PAIN 58
600 BACK INJURY 57
601 BLADDER CANCER 57
602 FRUSTRATION TOLERANCE DECREASED 57
603 INCORRECT DRUG ADMINISTRATION RATE 57
604 INCORRECT PRODUCT STORAGE 57
605 MENISCUS INJURY 57
606 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 57
607 SPINAL DISORDER 57
608 CATARACT OPERATION 56
609 DEVICE PHYSICAL PROPERTY ISSUE 56
610 DYSKINESIA 56
611 GLOMERULAR FILTRATION RATE DECREASED 56
612 PARALYSIS 56
613 RIB FRACTURE 56
614 SCAB 56
615 THROAT CLEARING 56
616 AORTIC ANEURYSM 55
617 BLOOD CALCIUM INCREASED 55
618 DRUG-INDUCED LIVER INJURY 55
619 GLOSSODYNIA 55
620 LACK OF ADMINISTRATION SITE ROTATION 55
621 LIVER FUNCTION TEST ABNORMAL 55
622 NASAL DISCOMFORT 55
623 NERVE INJURY 55
624 ORAL DISCOMFORT 55
625 QUALITY OF LIFE DECREASED 55
626 ACUTE CORONARY SYNDROME 54
627 BLOOD TRIGLYCERIDES ABNORMAL 54
628 EAR CONGESTION 54
629 HYPERLIPIDAEMIA 54
630 HYPOPHAGIA 54
631 INJECTION SITE SCAR 54
632 MOOD ALTERED 54
633 OVERDOSE 54
634 PROSTATIC SPECIFIC ANTIGEN INCREASED 54
635 ANAPHYLACTIC SHOCK 53
636 BLOOD UREA INCREASED 53
637 C-REACTIVE PROTEIN INCREASED 53
638 EYE HAEMORRHAGE 53
639 PARANASAL SINUS DISCOMFORT 53
640 CAROTID ARTERY STENOSIS 52
641 FEAR 52
642 SARS-COV-2 TEST POSITIVE 52
643 SHOULDER OPERATION 52
644 TRIGGER FINGER 52
645 VARICOSE VEIN 52
646 APPLICATION SITE SWELLING 51
647 EMOTIONAL DISTRESS 51
648 PHOTOSENSITIVITY REACTION 51
649 RASH VESICULAR 51
650 SKIN MASS 51
651 SPUTUM DISCOLOURED 51
652 TOOTH EXTRACTION 51
653 ANEURYSM 50
654 AORTIC VALVE REPLACEMENT 50
655 COLITIS ULCERATIVE 50
656 MUSCLE INJURY 50
657 NASAL DISORDER 50
658 BLADDER DISORDER 49
659 HAEMOPTYSIS 49
660 IMPAIRED GASTRIC EMPTYING 49
661 INCORRECT PRODUCT ADMINISTRATION DURATION 49
662 LIVER INJURY 49
663 PAIN OF SKIN 49
664 SENSORY DISTURBANCE 49
665 TOOTH FRACTURE 49
666 BLINDNESS UNILATERAL 48
667 BREAST PAIN 48
668 CONCUSSION 48
669 DERMATITIS ALLERGIC 48
670 DERMATITIS ATOPIC 48
671 EATING DISORDER 48
672 IMPAIRED DRIVING ABILITY 48
673 NASAL DRYNESS 48
674 PULMONARY MASS 48
675 SCAR 48
676 SKIN CANCER 48
677 VENTRICULAR EXTRASYSTOLES 48
678 ANGER 47
679 BACTERIAL INFECTION 47
680 BODY TEMPERATURE INCREASED 47
681 EMOTIONAL DISORDER 47
682 GRIP STRENGTH DECREASED 47
683 MYOCARDIAL ISCHAEMIA 47
684 ORAL MUCOSAL BLISTERING 47
685 PHARYNGITIS STREPTOCOCCAL 47
686 POLYMYALGIA RHEUMATICA 47
687 VASCULAR STENT STENOSIS 47
688 AORTIC STENOSIS 46
689 APPLICATION SITE HAEMORRHAGE 46
690 DISEASE RECURRENCE 46
691 DRUG ADMINISTERED AT INAPPROPRIATE SITE 46
692 HEART VALVE REPLACEMENT 46
693 IMPAIRED QUALITY OF LIFE 46
694 PANCREATITIS ACUTE 46
695 PRODUCT DISPENSING ISSUE 46
696 RESPIRATORY SYMPTOM 46
697 TOOTH INFECTION 46
698 VASCULITIS 46
699 EXERCISE TOLERANCE DECREASED 45
700 HIP SURGERY 45
701 INTERNAL HAEMORRHAGE 45
702 LYMPHOMA 45
703 MICTURITION URGENCY 45
704 MUSCLE RUPTURE 45
705 ONYCHOCLASIS 45
706 TRANSAMINASES INCREASED 45
707 DIABETES MELLITUS INADEQUATE CONTROL 44
708 FEMUR FRACTURE 44
709 HYPERTHYROIDISM 44
710 MITRAL VALVE INCOMPETENCE 44
711 SINUS PAIN 44
712 COLONOSCOPY 43
713 CRYING 43
714 EAR DISORDER 43
715 HEART RATE ABNORMAL 43
716 HEPATITIS 43
717 LIGAMENT SPRAIN 43
718 PERICARDIAL EFFUSION 43
719 PRODUCT LABEL CONFUSION 43
720 REHABILITATION THERAPY 43
721 RESPIRATORY DISTRESS 43
722 ANAL INCONTINENCE 42
723 APPLICATION SITE ERYTHEMA 42
724 BLOOD SODIUM DECREASED 42
725 LIPIDS ABNORMAL 42
726 ORTHOSTATIC HYPOTENSION 42
727 PERIPHERAL VASCULAR DISORDER 42
728 PHOTOPHOBIA 42
729 SKIN SWELLING 42
730 THERAPEUTIC RESPONSE SHORTENED 42
731 TONGUE DISCOMFORT 42
732 ANOSMIA 41
733 CORONAVIRUS INFECTION 41
734 FRACTURE 41
735 INFARCTION 41
736 JOINT RANGE OF MOTION DECREASED 41
737 MOOD SWINGS 41
738 MYASTHENIA GRAVIS 41
739 PRODUCT PRESCRIBING ISSUE 41
740 RESPIRATION ABNORMAL 41
741 RESPIRATORY FAILURE 41
742 SKIN FISSURES 41
743 TENDON DISORDER 41
744 BRAIN INJURY 40
745 CROHN^S DISEASE 40
746 FOOD ALLERGY 40
747 HEPATIC CIRRHOSIS 40
748 HEPATIC PAIN 40
749 HIATUS HERNIA 40
750 HYPERAESTHESIA 40
751 ISCHAEMIC STROKE 40
752 MOUTH SWELLING 40
753 MULTIPLE ALLERGIES 40
754 NODULE 40
755 POOR QUALITY PRODUCT ADMINISTERED 40
756 RED BLOOD CELL COUNT DECREASED 40
757 SHOULDER ARTHROPLASTY 40
758 SKIN ODOUR ABNORMAL 40
759 VITREOUS FLOATERS 40
760 INJECTION RELATED REACTION 39
761 MEDICAL DEVICE IMPLANTATION 39
762 MULTIPLE SCLEROSIS 39
763 PANCREATIC DISORDER 39
764 PAROSMIA 39
765 WRONG SCHEDULE 39
766 AUTOIMMUNE HEPATITIS 38
767 BLOOD BILIRUBIN INCREASED 38
768 CARDIO-RESPIRATORY ARREST 38
769 COLON CANCER 38
770 CONTRAINDICATED PRODUCT ADMINISTERED 38
771 ESSENTIAL HYPERTENSION 38
772 EXTRASYSTOLES 38
773 FACIAL PARALYSIS 38
774 GLYCOSYLATED HAEMOGLOBIN DECREASED 38
775 HAEMORRHOIDS 38
776 MIDDLE EAR EFFUSION 38
777 NOCTURIA 38
778 PERIPHERAL ARTERY OCCLUSION 38
779 TREATMENT FAILURE 38
780 WEIGHT FLUCTUATION 38
781 ACCIDENTAL OVERDOSE 37
782 BLOOD IRON DECREASED 37
783 BLOOD TESTOSTERONE DECREASED 37
784 GALLBLADDER OPERATION 37
785 GENERALISED OEDEMA 37
786 HEPATIC ENZYME ABNORMAL 37
787 HOSPICE CARE 37
788 INTERSTITIAL LUNG DISEASE 37
789 INTERVERTEBRAL DISC DEGENERATION 37
790 JOINT LOCK 37
791 MATERNAL EXPOSURE DURING PREGNANCY 37
792 OBESITY 37
793 OVERWEIGHT 37
794 PANCREATIC CARCINOMA 37
795 PERIORBITAL SWELLING 37
796 POOR QUALITY DEVICE USED 37
797 PRODUCT PHYSICAL ISSUE 37
798 TEMPERATURE INTOLERANCE 37
799 TONGUE DISORDER 37
800 ULCER 37
801 VEIN DISORDER 37
802 VENTRICULAR TACHYCARDIA 37
803 APATHY 36
804 APHTHOUS ULCER 36
805 CARDIAC VALVE DISEASE 36
806 CONJUNCTIVITIS 36
807 DECREASED IMMUNE RESPONSIVENESS 36
808 FAECES SOFT 36
809 FURUNCLE 36
810 GASTRIC ULCER 36
811 PALLOR 36
812 PETECHIAE 36
813 POST PROCEDURAL INFECTION 36
814 PULMONARY FIBROSIS 36
815 SPINAL OSTEOARTHRITIS 36
816 TOOTH ABSCESS 36
817 CHEMOTHERAPY 35
818 CHOKING SENSATION 35
819 FOOT OPERATION 35
820 INJECTION SITE PAPULE 35
821 LIQUID PRODUCT PHYSICAL ISSUE 35
822 PRODUCT SUBSTITUTION ISSUE 35
823 PROSTATIC DISORDER 35
824 SPINAL FUSION SURGERY 35
825 SUBCLAVIAN VEIN THROMBOSIS 35
826 VITAMIN D DEFICIENCY 35
827 EYE INFECTION 34
828 FOOT DEFORMITY 34
829 FOREIGN BODY IN THROAT 34
830 INTERCEPTED MEDICATION ERROR 34
831 PRODUCT USE COMPLAINT 34
832 ARTERIAL DISORDER 33
833 BLADDER PAIN 33
834 CAROTID ARTERIOSCLEROSIS 33
835 COVID-19 PNEUMONIA 33
836 DEVICE BREAKAGE 33
837 GASTROINTESTINAL INFLAMMATION 33
838 HYPOKALAEMIA 33
839 IMMUNODEFICIENCY 33
840 MOUTH ULCERATION 33
841 NECK SURGERY 33
842 URINE ABNORMALITY 33
843 BLOOD THYROID STIMULATING HORMONE INCREASED 32
844 CANDIDA INFECTION 32
845 CYST 32
846 HYPOXIA 32
847 INJECTION SITE SCAB 32
848 INTERNATIONAL NORMALISED RATIO INCREASED 32
849 NAIL DISORDER 32
850 ORAL CANDIDIASIS 32
851 PRODUCT DISTRIBUTION ISSUE 32
852 UPPER RESPIRATORY TRACT CONGESTION 32
853 VITAMIN D DECREASED 32
854 ACTIVITIES OF DAILY LIVING IMPAIRED 31
855 BLEPHAROSPASM 31
856 BLOOD MAGNESIUM DECREASED 31
857 BRAIN NEOPLASM 31
858 CLOSTRIDIUM DIFFICILE INFECTION 31
859 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31
860 GUILLAIN-BARRE SYNDROME 31
861 HYPERTENSIVE CRISIS 31
862 HYPONATRAEMIA 31
863 PLASMA CELL MYELOMA 31
864 PRODUCT ODOUR ABNORMAL 31
865 SKIN ATROPHY 31
866 THERAPY CHANGE 31
867 ATRIOVENTRICULAR BLOCK 30
868 BLOOD DISORDER 30
869 COMPLICATION ASSOCIATED WITH DEVICE 30
870 DECREASED ACTIVITY 30
871 GINGIVAL BLEEDING 30
872 HYSTERECTOMY 30
873 INTRACRANIAL ANEURYSM 30
874 LIP DRY 30
875 ORAL DISORDER 30
876 PROSTATOMEGALY 30
877 PULMONARY THROMBOSIS 30
878 RENAL FUNCTION TEST ABNORMAL 30
879 THERAPY PARTIAL RESPONDER 30
880 APPETITE DISORDER 29
881 BLOOD ALKALINE PHOSPHATASE INCREASED 29
882 BLOOD TRIGLYCERIDES DECREASED 29
883 BLOOD URIC ACID INCREASED 29
884 DEAFNESS UNILATERAL 29
885 EMPHYSEMA 29
886 FEELING OF BODY TEMPERATURE CHANGE 29
887 FORMICATION 29
888 GASTROINTESTINAL INFECTION 29
889 HAEMORRHAGIC DIATHESIS 29
890 HIGH DENSITY LIPOPROTEIN ABNORMAL 29
891 INITIAL INSOMNIA 29
892 INTRAOCULAR PRESSURE INCREASED 29
893 LEUKAEMIA 29
894 LIBIDO DECREASED 29
895 MENTAL STATUS CHANGES 29
896 POLYNEUROPATHY 29
897 POST PROCEDURAL HAEMORRHAGE 29
898 RESPIRATORY ARREST 29
899 VAGINAL HAEMORRHAGE 29
900 ATRIAL FLUTTER 28
901 CARDIAC ABLATION 28
902 CATHETER PLACEMENT 28
903 COLITIS MICROSCOPIC 28
904 DEVICE DEPLOYMENT ISSUE 28
905 DYSLIPIDAEMIA 28
906 ENERGY INCREASED 28
907 EPILEPSY 28
908 GINGIVAL PAIN 28
909 HERNIA REPAIR 28
910 HICCUPS 28
911 INTERVERTEBRAL DISC DISORDER 28
912 LUNG INFECTION 28
913 PELVIC PAIN 28
914 PHARYNGEAL DISORDER 28
915 RENAL TRANSPLANT 28
916 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28
917 SWELLING OF EYELID 28
918 ANGIOPLASTY 27
919 APPLICATION SITE MASS 27
920 CHAPPED LIPS 27
921 CHEILITIS 27
922 DRUG ERUPTION 27
923 DRUG PRESCRIBING ERROR 27
924 FOOD CRAVING 27
925 FOOD POISONING 27
926 IMPLANTABLE DEFIBRILLATOR INSERTION 27
927 INDURATION 27
928 JAUNDICE 27
929 LACERATION 27
930 MUSCLE DISCOMFORT 27
931 PRODUCT AVAILABILITY ISSUE 27
932 REFUSAL OF TREATMENT BY PATIENT 27
933 RETINAL DETACHMENT 27
934 SALIVARY HYPERSECRETION 27
935 SKIN INFECTION 27
936 SPONDYLITIS 27
937 BASAL CELL CARCINOMA 26
938 CAROTID ARTERY DISEASE 26
939 DELIRIUM 26
940 ERYTHEMA MULTIFORME 26
941 HAEMORRHAGIC STROKE 26
942 HEMIPARESIS 26
943 INCONTINENCE 26
944 INJECTION SITE LACERATION 26
945 LYMPHOEDEMA 26
946 PRODUCT PACKAGING ISSUE 26
947 PROTEINURIA 26
948 RED BLOOD CELL SEDIMENTATION RATE INCREASED 26
949 SUPRAVENTRICULAR TACHYCARDIA 26
950 THYROID MASS 26
951 URINARY TRACT DISORDER 26
952 WEIGHT LOSS POOR 26
953 ASPHYXIA 25
954 BLINDNESS TRANSIENT 25
955 BLOOD BLISTER 25
956 BREAST CANCER FEMALE 25
957 DIABETIC NEUROPATHY 25
958 EMBOLISM VENOUS 25
959 HAIR TEXTURE ABNORMAL 25
960 HYPERKALAEMIA 25
961 LIPOMA 25
962 OSTEOMYELITIS 25
963 RENAL CYST 25
964 SKIN WARM 25
965 STENOSIS 25
966 WAIST CIRCUMFERENCE INCREASED 25
967 AGGRESSION 24
968 COAGULOPATHY 24
969 DIARRHOEA HAEMORRHAGIC 24
970 EXFOLIATIVE RASH 24
971 HEPATIC FAILURE 24
972 JOINT EFFUSION 24
973 LIMB MASS 24
974 MALIGNANT MELANOMA 24
975 MIGRAINE WITH AURA 24
976 MUSCLE RIGIDITY 24
977 PERICARDITIS 24
978 PIGMENTATION DISORDER 24
979 PLATELET COUNT INCREASED 24
980 PULMONARY PAIN 24
981 TOE AMPUTATION 24
982 TRICUSPID VALVE INCOMPETENCE 24
983 VENTRICULAR HYPOKINESIA 24
984 ATAXIA 23
985 CARDIOGENIC SHOCK 23
986 COMPUTERISED TOMOGRAM HEART ABNORMAL 23
987 DRUG RESISTANCE 23
988 IMMOBILE 23
989 JOINT DISLOCATION 23
990 LYME DISEASE 23
991 NECK INJURY 23
992 NEPHROTIC SYNDROME 23
993 PANCYTOPENIA 23
994 PANIC REACTION 23
995 PNEUMONIA ASPIRATION 23
996 PROCEDURAL COMPLICATION 23
997 SKIN TIGHTNESS 23
998 SUDDEN DEATH 23
999 TYPE 1 DIABETES MELLITUS 23